Related by context. Frequent words. (Click for all words.) 65 HER2 positive metastatic breast 65 pancreatic adenocarcinoma 64 malignant pleural mesothelioma 64 castrate resistant prostate cancer 63 primary peritoneal 63 ovarian breast 62 bladder cancers 62 gastrointestinal stromal tumors 62 metastatic castration resistant 62 colorectal lung 61 lung pancreatic 61 metastatic castrate resistant 60 undergone hysterectomy 60 metastatic renal cell carcinoma 60 colorectal carcinoma 60 recurrent prostate cancer 59 advanced carcinoid 59 plus prednisone 59 adjuvant radiation 59 neoadjuvant therapy 59 heavily pretreated 59 lymphoma leukemia 59 prostate pancreatic 59 metastatic lung cancer 59 mRCC 59 unresectable 59 advanced adenomas 59 metastatic RCC 59 cholangiocarcinoma 59 lung metastases 59 breast carcinoma 58 gastrointestinal cancers 58 multiple myeloma MM 58 squamous cell cancer 58 HRPC 58 Proxinium TM 58 myeloproliferative disorders 58 GnRH agonists 58 HER2 negative 58 metastatic prostate cancer 58 metastatic bone 58 diagnosed GBM 58 lobular carcinoma 57 secondary hyperparathyroidism 57 gastrointestinal stromal tumors GIST 57 refractory chronic lymphocytic 57 Carcinoma 57 FOLFOX4 57 GISTs 57 androgen independent 57 HNSCC 57 non squamous 57 metastatic hormone refractory 57 Eculizumab 57 ThermoDox R 57 recurrent glioblastoma 57 idiopathic pulmonary fibrosis IPF 57 gastric cancers 57 docetaxel chemotherapy 56 Metastatic 56 recurrent ovarian cancer 56 IV metastatic melanoma 56 Irinotecan 56 ocular melanoma 56 receiving VELCADE 56 hepatocellular cancer 56 mCRC patients 56 Chronic Lymphocytic Leukemia 56 superficial bladder cancer 56 leukemia ALL 56 IV melanoma 56 Metastatic Colorectal Cancer 56 lymphoma CTCL 56 undergoing coronary artery 56 epithelial ovarian cancer 56 squamous cell cancers 56 soft tissue sarcomas 56 leukaemias 56 diagnosed Ph + 56 primary hypercholesterolemia 56 underwent hysterectomy 56 testicular cancers 56 Idiopathic Pulmonary Fibrosis 56 SHPT 56 squamous cell 56 chemoradiotherapy 56 relapsed multiple myeloma 56 patients undergoing percutaneous 56 esophageal cancers 56 olaparib 56 EGFR expressing metastatic colorectal 55 metastatic breast 55 medullary thyroid cancer 55 AAT deficiency 55 rheumatoid arthritis lupus 55 leukemia CLL 55 Vandetanib 55 metastatic liver 55 active ankylosing spondylitis 55 liver transplant recipients 55 underwent lumpectomy